Herbalife Nutrition

Herbalife Nutrition

World Rank (Jan-05-2024)
6,985
Market Cap (Jan-05-2024)
1.425 Billion USD
World Rank (Jul-30-2023)
6,451
Market Cap (Jul-30-2023)
1.658 Billion USD
World Rank (Jan-07-2022)
3,361
Market Cap (Jan-07-2022)
4.854 Billion USD
World Rank (Jan-01-2021)
2,612
Market Cap (Jan-01-2021)
5.844 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
HLF
Market Cap (Mar-08-2026)
1.60
Employee Count
10,800
Employee Count as of Date
As on 2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
5,204 Million USD
Annual Operating Income in USD
545 Million USD
Annual Net Income in USD
321 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
2,732 Million USD
Total Liabilities in USD
3,997 Million USD
Total Equity in USD
-1,265 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
HealthCare Products
FMCG
Package Foods
Food Products
Company Website
HERBALIFE NUTRITION LTD.
Yahoo
Yahoo @ NYSE
Company Profile

Herbalife Nutrition is a Multi level marketing and Healthcare company. The company products are personalized protein powder, cell u loss advanced, cell activator tablets, multivitamin mineral and herbal tablets, herbal control, shakemate and formula 1 nutritional shake mix. Its nutrition, weight-management products are available exclusively through its more than 2.3 million independent Associates in more than 90 countries. The headquarters is in USA.

Annual Results Summary

HERBALIFE NUTRITION - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-20225,204545321
Dec-20215,802734447
Dec-20205,541640372
Dec-20194,877568311
Dec-20184,891683296
Balance Sheet Summary

Total Assets as on Dec-2022 was 2,732 Million USD.

Total Liabilities as on Dec-2022 was 3,997 Million USD.

Total Equity as on Dec-2022 was -1,265 Million USD.

Founded Year
1980
IPO Year
2004
Stock Exchange
NYSE
Nasdaq Sector
Health Care
Nasdaq Industry
Other Pharmaceuticals

Share